Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.22.2
Stockholders' Equity (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Stockholders' Equity (Details) [Line Items]        
Vest contract term     24 months  
Stock-based compensation expense related to amortization $ 8,100   $ 14,175  
Stock based compensation expense 855,674      
Share-Based Payment Arrangement, Noncash Expense     1,601,854  
General and administrative expenses 711,264 $ 344,095 1,375,673 $ 1,436,494
Research and development expenses 144,410   226,181  
Unrecognized stock based compensation expense $ 5,432,652   $ 5,432,652  
Weighted average remaining vesting period     2 years 7 months 6 days  
Restricted Stock Units (RSUs) [Member]        
Stockholders' Equity (Details) [Line Items]        
Restricted shares issued (in Shares) 12,000   12,000  
Aggregate issuance date fair value     $ 48,600  
Unrecognized stock based compensation expense $ 34,425   $ 34,425  
Weighted average remaining vesting period     1 year 6 months  
Common Stock Issued For Services [Member]        
Stockholders' Equity (Details) [Line Items]        
Aggregate shares (in Shares) 56,579   107,898  
Aggregate issuance date fair value $ 75,627   $ 225,346